BARDA EXERCISES OPTIONS WITH CANGENE WORTH US$61 MILLION UNDER BOTULISM …

… the agency within the US Department of Health and Human Services that administers its biodefence stockpiling contracts, will exercise options under a botulism antitoxin ("BAT") supply contract, which are expected to generate approximately US$61 …
See all stories on this topic »